Caricamento pagina
hero_alba_Syringes_MB

Syringe Systems

Alba® Syringe: Innovative Solution for Highly Sensitive Biologics and Ophthalmics

Alba line Syringes Nest Needle detail

Complex biologic drugs encounter several challenges in primary packaging. Any interaction between the drug and the prefilled syringe can affect stability and treatment efficacy. For instance, silicone could interact with the drug, and tungsten residues may lead to protein degradation or aggregation.

Alba® syringes represent the best-in-class solution for highly sensitive biologics and ophthalmic applications, minimizing the risk of drug-container interaction and addressing the key requirements of protein-based drugs, and minimizing adsorption, aggregation and inorganic extractable interaction. 

Alba line Syringes handling

Alba® Syringes: Advanced Coating for Enhanced Stability for Highly Sensitive Drugs

All Alba® products have an internal coating based on cross-linked silicone oil. It ensures that particle levels - caused by silicone migration during container storage - are significantly lower than standard siliconization technologies.

Moreover, the internal treatment offers superior and stable gliding performances, reducing the risk of functional issues when combined with autoinjectors, even throughout shelf-life.

Alba® syringes are only available as prefillable solutions in our EZ-fill® configuration.

Watch the video about Alba® syringe features and advantages and discover the manufacturing process. 

Aidaptus autoinjector with alba syringe in hand

Optimized Glass Syringes for Autoinjectors: Consistent Injection Performance

The low silicone-drug interaction helps to maintain the injection time and dose delivery in combination with an autoinjector.

Alba® Syringes Mitigate Packaging-Related Risks, Enhance Drug Stability and Provide Consistent Injection Performance

Alba® breakthrough solution employs a plasma treatment on silicone-oil coating, creating a layer that ensures exceptional stability and performance over time.

Key Benefits of Alba® Syringes

  • 184_Syringe_Alba

    De-risking drug-silicone interaction
    Near-zero subvisible particles level compared to conventional sprayed-on siliconized PFS

  • 97_Time OK

    Injection Time consistency
    Cross-linked coating prevents silicone migration that impacts the extrusion forces and injection time.

  • 65_Container Interaction

    Shelf-life improvement
    Alba® inner coating does not undergo critical variations after contact with drug products, even in presence of silicone-aggressive or highly concentrated solutions (e.g. surfactants).

  • 92B_Filled Syringe_particles

    Inorganic extractable mitigation
    The coating between the drug and the glass reduces the amount of inorganic extractables

Optimal Syringe Solution for Biologics, mRNA, and Ophthalmic Treatments

Alba® syringes meet the needs of highly sensitive biologic drugs.

  • 431_Protein-peptide

    Protein-based therapeutics

  • 252_Eye

    Ophthalmic applications

  • 430_mRNA

    mRNA-based applications

Other Syringe Systems

preview_nexa_Syringes_Solutions

Nexa® Syringes

preview_fina_Syringes

Fina® Syringes

preview_dual chamber syringes

Dual-Chamber Syringes

preview_itc

Integrated Tip Cap (ITC)

preview_stw_needle

Special Thin-Wall Needle (sTW Needle)

Alba line Syringes Nest Needle detail

White Paper: Solving the Silicone Challenge in Syringes

How Stevanato Group’s breakthrough Alba® platform ensures stability for sensitive drugs

Read now
Alba line Syringes handling

White Paper: Container Selection for a Highly Sensitive Drug Product: a Success Story

Discover the importance for pharmaceutical companies to utilize the experience of container suppliers from start to finish.

Read now